Statistics
Publications
2
Citations
140
H-Index
2
Active since
2019
Affiliations
Tempus Labs (United States)(Current)
Irvin Ho is an author at Tempus Labs (United States) specializing in programmed death-ligand 1 biomarker, molecular oncology, and programmed cell death ligand 1 inhibition.
Publications per year
2019–2022
2
2
Lingdao Sha, Bolesław L. Osinski, Irvin Ho et al. · Journal of Pathology Informatics · 2019 · 127 citations · Full text
1–2 of 2